Tacrolimus is a generic for Astellas Pharma's Prograf and is indicated for preventing organ rejection in patients receiving kidney, liver or heart transplants. Accord's tacrolimus oral capsules might increase the risk for tacrolimus-associated toxicity, the FDA said, because data showed a peak blood level that was higher than the branded drug.